Low CD25 in ALK+ Anaplastic Large Cell Lymphoma Is Associated with Older Age, Thrombocytopenia, and Increased Expression of Surface CD3 and CD8
most cases of ALK+ ALCL highly express CD25 which is a potential target for therapy. ALK+ ALCL with low CD25 expression is associated with older patient age and increased frequency of thrombocytopenia and surface CD3 and CD8 expression.
Authors
- Leonard Jeffrey Medeiros (ORCID: https://orcid.org/0000-0001-6577-8006)
- C. Cameron Yin (ORCID: https://orcid.org/0000-0001-6630-4128)
- Lianqun Qiu (ORCID: https://orcid.org/0000-0002-4218-4587)
- Hong Fang (ORCID: https://orcid.org/0000-0003-1780-5959)
- Swaminathan P. Iyer (ORCID: https://orcid.org/0000-0002-1646-813X)
- Qing Wei (ORCID: https://orcid.org/0000-0003-0141-9682)
- Guilin Tang (ORCID: https://orcid.org/0000-0002-9482-4806)
- Luis Malpica (ORCID: https://orcid.org/0000-0002-7082-1846)
- M. James You
- Zhenya Tang (ORCID: https://orcid.org/0000-0002-8079-9945)
- E Shuyu
- Sa A. Wang (ORCID: https://orcid.org/0000-0001-9385-9911)
- Wei Wang (ORCID: https://orcid.org/0000-0001-6821-4556)
- Jie Xu (ORCID: https://orcid.org/0000-0001-9163-3898)
- Shaoying Li (ORCID: https://orcid.org/0000-0002-6857-0523)
- Pei Lin
Institutions
- The University of Texas MD Anderson Cancer Center (US)
Publication Details
- Journal
- Cancers
- Published
- 2025-05-25
- DOI
- https://doi.org/10.3390/cancers17111767
- Citations
- 1
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.47